FDA DEVICE FACTS
Xpert MRSA/SA SSTI
Cepheid®
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Xpert® MR.SA/SA Skin and Soft Tissue Infection test (Xpert MR.SA/SA SSTI test) performed on the GeneXpert® Instrument Systems is a qualitative in vitro diagnostic test intended for the detection of Staphylococcus aureus (SA) and methicillin-resistant Staphylococc us aureus (MR.SA) from skin and soft tissue infection swabs. The test utilizes automated real-time polymerase chain reaction (PCR) to detect MR.SA/SA DNA. The Xpert MR.SA/SA SSTI test is indic ated for use in conjunction with other laboratory tests, such as microbiology culture, and clinica l data available to the clinician as an aid in the detection of MR.SA/SA from skin and soft tissue infections. The Xpert MR.SA/SA SSTI test is not intended to monitor treatment for MR.SA/SA infections. Concomitant cultures for SA and MR.SA are necessary to recover organisms for susceptibility testing or epidemiological typing. In a mi xed culture containing MR.SA/SA and other organisms ( e.g., Gram-negative bacilli, yeast), results can be false negative or variable depending on the concentration of MR.SA/SA present, particularly if the concentration of MR.SA/SA is close to the limit of detection (LoD) of the test.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。